Inherent Immune Cell Variation Within Colonic Segments Presents Challenges for Clinical Trial Design is a research paper published in Journal of Crohn s and Colitis (2020). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: DK108670
National Institutes of Health
Grant: DK118927
National Institutes of Health
Grant: BLRD-I01 BX003436
Takeda Pharmaceuticals U.S.A.
Grant: IISR-2017–102050
San Diego Digestive Diseases Research Center
Grant: P30 DK120515
SCyTOF Mass Cytometer
Grant: OD018499-01
BLRD VA
Grant: I01 BX003436
NIH HHS
Grant: S10 OD018499
NIAID NIH HHS
Grant: R21 AI149636
NIDDK NIH HHS
Grant: R01 DK108670
NIDDK NIH HHS
Grant: R21 DK118927
National Institutes of Health
Grant: 1R21DK118927-01A1
High Dimensional Mass Cytometry Analysis of the Effects of Vedolizumab in Intestinal Cellular Subsets and its Correlation with Clinical Parameters
National Institutes of Health
Grant: 5I01BX003436-02
Dendritic Cell Regulation by Sphingosine-1-phosphate in Inflammatory Bowel Disease
National Institutes of Health
Grant: 1S10OD018499-01
CyTOF Mass Cytometer
National Institutes of Health
Grant: 5R01DK108670-02
Novel Traffic-targeted Therapies for IBD
National Institutes of Health
Grant: 5P30DK120515-04
San Diego Digestive Diseases Research Center
Chiba University-UC San Diego Program in Mucosal Immunology
FWCI
0.52
Citation Percentile
0.6%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals